NCT01836575 Alimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung Cancer in Patients Performance Status 2 Status COMPLETED Phase PHASE3
NCT01836341 Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation Status WITHDRAWN Phase PHASE1
NCT01836029 Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2
NCT01828736 Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma Status COMPLETED Phase PHASE2
NCT01828099 LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT01827384 MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene Variations Status COMPLETED Phase PHASE2
NCT01822496 Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT01820325 Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer Status TERMINATED Phase PHASE1
NCT01818063 Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer Status COMPLETED Phase PHASE2
NCT01815242 Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer - Triple Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT01809210 Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT01803282 Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01802749 Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer Status UNKNOWN Phase PHASE3
NCT01795586 A Phase I Dose Escalation Study of Eribulin Plus Weekly Carboplatin for Metastatic Breast Patients Status COMPLETED Phase PHASE1
NCT01783535 Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01783197 Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC Status COMPLETED Phase PHASE1
NCT01779050 Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells Status TERMINATED Phase PHASE2
NCT01769391 A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01763645 A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT01752686 A Phase III Trial of Carboplatin as Adjuvant Chemotherapy in Triple Negative Breast Cancer Status UNKNOWN Phase PHASE3